Designing Safer Analgesics via μ-Opioid Receptor Pathways.

about

The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice

P2860

Q52628758-73828693-9AAC-456E-A98B-B4F929658232 Q57095558-F53FDE9A-5F50-441D-B95B-24947C4ACC79

P2860

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

Item

http://www.wikidata.org/entity/Q43075987

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@en

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@nl

type

Item

label

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@en

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@nl

prefLabel

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@en

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@nl

P1476

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

@en

P2093

Dillon McCarthy

http://www.w3.org/2001/XMLSchema#string

H C Stephen Chan

http://www.w3.org/2001/XMLSchema#string

Jianing Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the human κ-opioid receptor in complex with JDTic

Activation and allosteric modulation of a muscarinic acetylcholine receptor

Crystal structure of the β2 adrenergic receptor-Gs protein complex

Structure-based discovery of opioid analgesics with reduced side effects.

Biological membranes

Structural basis for bifunctional peptide recognition at human δ-opioid receptor

Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide

Crystal structure of the µ-opioid receptor bound to a morphinan antagonist

Generic GPCR residue numbers - aligning topology maps while minding the gaps

Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers

P304

1016-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TIPS.2017.08.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shuguang Yuan

Krzysztof Palczewski

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28935293

http://www.w3.org/2001/XMLSchema#string

P932

5690544

http://www.w3.org/2001/XMLSchema#string

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

about

P2860

P2860

Designing Safer Analgesics via μ-Opioid Receptor Pathways.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932